Christoph Klawe

1.0k total citations
21 papers, 725 citations indexed

About

Christoph Klawe is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Molecular Biology. According to data from OpenAlex, Christoph Klawe has authored 21 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Christoph Klawe's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Substance Abuse Treatment and Outcomes (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Christoph Klawe is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Substance Abuse Treatment and Outcomes (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Christoph Klawe collaborates with scholars based in Germany, Switzerland and United Kingdom. Christoph Klawe's co-authors include Armin Szegedi, Ion Anghelescu, Christoph Fehr, Norbert Dahmen, Matthias Maschke, Otto Benkert, Ralf Kohnen, Matthias J. Müller, Christoph Hiemke and Lutz G. Schmidt and has published in prestigious journals such as Psychiatry Research, The Journal of Clinical Psychiatry and Alcoholism Clinical and Experimental Research.

In The Last Decade

Christoph Klawe

21 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Klawe Germany 13 218 174 152 144 132 21 725
Ihn‐Geun Choi South Korea 14 126 0.6× 68 0.4× 142 0.9× 143 1.0× 84 0.6× 28 674
Amira Pierucci‐Lagha United States 11 270 1.2× 65 0.4× 214 1.4× 122 0.8× 75 0.6× 13 664
Begoña Gonzalvo Spain 14 308 1.4× 118 0.7× 225 1.5× 69 0.5× 231 1.8× 30 680
Joar Guterstam Sweden 10 229 1.1× 107 0.6× 147 1.0× 90 0.6× 227 1.7× 26 601
P.J. Geerlings Netherlands 10 234 1.1× 69 0.4× 279 1.8× 111 0.8× 86 0.7× 12 708
Raymond F. Anton United States 7 226 1.0× 62 0.4× 394 2.6× 252 1.8× 103 0.8× 9 802
K Kadlec Canada 8 297 1.4× 108 0.6× 197 1.3× 80 0.6× 104 0.8× 10 500
Rasmon Kalayasiri Thailand 17 218 1.0× 135 0.8× 150 1.0× 53 0.4× 146 1.1× 40 588
J. Böning Germany 16 297 1.4× 66 0.4× 168 1.1× 80 0.6× 266 2.0× 47 904
Robert J. Fitch United States 6 516 2.4× 85 0.5× 161 1.1× 79 0.5× 172 1.3× 6 877

Countries citing papers authored by Christoph Klawe

Since Specialization
Citations

This map shows the geographic impact of Christoph Klawe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Klawe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Klawe more than expected).

Fields of papers citing papers by Christoph Klawe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Klawe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Klawe. The network helps show where Christoph Klawe may publish in the future.

Co-authorship network of co-authors of Christoph Klawe

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Klawe. A scholar is included among the top collaborators of Christoph Klawe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Klawe. Christoph Klawe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stephan, Christoph, et al.. (2015). Cryptococcosis due to Cryptococcus gattii in Germany from 2004–2013. International Journal of Medical Microbiology. 305(7). 719–723. 20 indexed citations
2.
Klawe, Christoph & Matthias Maschke. (2009). Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opinion on Pharmacotherapy. 10(9). 1495–1500. 42 indexed citations
3.
Putzki, Norman, Özgür Yaldizli, M. Mäurer, et al.. (2009). Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi‐center study in German speaking countries. European Journal of Neurology. 17(1). 31–37. 64 indexed citations
4.
Anghelescu, Ion, Christoph Klawe, Peter Singer, et al.. (2008). Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. The World Journal of Biological Psychiatry. 11(2 Pt 2). 1–8. 14 indexed citations
5.
Fehr, Christoph, Thomas Sander, André Tadić, et al.. (2006). Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatric Genetics. 16(1). 9–17. 142 indexed citations
6.
Tadić, A., Norbert Dahmen, Armin Szegedi, et al.. (2004). Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal?induced seizures and delirium tremens. European Archives of Psychiatry and Clinical Neuroscience. 255(2). 129–135. 17 indexed citations
7.
Klawe, Christoph, Christoph Fehr, Peter Singer, et al.. (2004). The TPH intron 7 A218C polymorphism and TCI dimension scores in alcohol-dependent patients: hints to nonspecific psychopathology. Addictive Behaviors. 30(6). 1135–1143. 11 indexed citations
8.
Lange‐Asschenfeldt, Christian, Matthias J. Müller, Armin Szegedi, et al.. (2003). Symptom-Triggered versus Standard Chlormethiazole Treatment of Inpatient Alcohol Withdrawal: Clinical Implications from a Chart Analysis. European Addiction Research. 9(1). 1–7. 14 indexed citations
9.
Szegedi, Armin, Matthias J. Müller, Ion Anghelescu, et al.. (2003). Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients With Major Depression. The Journal of Clinical Psychiatry. 64(4). 413–420. 145 indexed citations
10.
Himmerich, Hubertus, Armin Szegedi, Christoph Klawe, Ion Anghelescu, & Matthias J. Müller. (2003). Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis. European Psychiatry. 18(6). 318–319. 9 indexed citations
11.
Anghelescu, Ion, Christoph Klawe, & Armin Szegedi. (2002). Add-On Combination and Maintenance Treatment: Case Series of Five Obese Patients with Different Eating Behavior. Journal of Clinical Psychopharmacology. 22(5). 521–524. 9 indexed citations
12.
Schumann, Günter, Dan Rujescu, Andrea Szegedi, et al.. (2002). Alcohol dependence is associated with a NMDA-receptor 2B gene variant. European Psychiatry. 17. 212–212. 2 indexed citations
13.
Schumann, Günter, Dan Rujescu, Andrea Szegedi, et al.. (2001). Alcohol dependence is associated with a NMDA-receptor 2B gene variant. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 105(7). 1 indexed citations
14.
Fehr, Christoph, et al.. (2001). Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25(5). 965–982. 35 indexed citations
15.
Anghelescu, Ion, Matthias J. Müller, Christoph Klawe, et al.. (2001). No Association Between the Dopamine D2 Receptor Taq I A1 Allele and Earlier Age of Onset of Alcohol Dependence According to Different Specified Criteria. Alcoholism Clinical and Experimental Research. 25(6). 805–809. 18 indexed citations
16.
Fehr, Christoph, Armin Szegedi, Ion Anghelescu, et al.. (2000). The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Research. 97(1). 1–10. 65 indexed citations
17.
Scheurich, Armin, Matthias J. Müller, Hermann Wetzel, et al.. (2000). Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).. Journal of Studies on Alcohol. 61(6). 916–919. 77 indexed citations
18.
19.
Mäkelä, Riikka, Mikko Uusi‐Oukari, Simo S. Oja, et al.. (1999). Furosemide Action on Cerebellar GABAA Receptors in Alcohol-Sensitive ANT Rats. Alcohol. 19(3). 197–205. 3 indexed citations
20.
Klawe, Christoph, et al.. (1997). P.6.063 Lorazepam for stupor and mutism: A double-blind placebo-controlled cross-over study. European Neuropsychopharmacology. 7. S283–S284. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ihn‐Geun Choi Breakdown of academic impact, for papers by Amira Pierucci‐Lagha Breakdown of academic impact, for papers by Begoña Gonzalvo Breakdown of academic impact, for papers by Joar Guterstam Breakdown of academic impact, for papers by P.J. Geerlings Breakdown of academic impact, for papers by Raymond F. Anton Breakdown of academic impact, for papers by K Kadlec Breakdown of academic impact, for papers by Rasmon Kalayasiri Breakdown of academic impact, for papers by J. Böning Breakdown of academic impact, for papers by Robert J. Fitch
Rankless by CCL
2026